Even though clodronate-mediated KC depletion improves hepatic steatosis in both models, we only observe a decrease in IL-1α expression in clodronate-treated DIO mouse livers compared with control mice (Fig. 5A). The gene discussed is IL1A; the disease is Hepatic steatosis.